| RS2527433777 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527434001 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527434028 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527434040 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527434089 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527434136 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527434580 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527435277 |
ACTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2527435672 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527435971 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527436130 |
ACTA1
|
Health Risk |
Likely pathogenic |
Alpha-actinopathy, Alpha-actinopathy |
| RS2527436136 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527436164 |
ACTA1
|
Health Risk |
Likely pathogenic |
Congenital myopathy, Congenital myopathy |
| RS2527436174 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527436245 |
ACTA1
|
Health Risk |
Pathogenic |
Myopathy, Myopathy |
| RS2527436292 |
ACTA1
|
Health Risk |
Pathogenic |
Congenital myopathy 2c, severe infantile |
| RS2527436311 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Actin accumulation myopathy, Congenital myopathy 2c |
| RS2527436317 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527436326 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527436614 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527436730 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527437067 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527437105 |
ACTA1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy, Congenital myopathy |
| RS2527437109 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527437138 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527437313 |
ACTA1
|
Health Risk |
Pathogenic |
ACTA1-related disorder, Nemaline myopathy |
| RS2527437375 |
ACTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2527437435 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527437709 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527437739 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myopathy 2c, severe infantile |
| RS2527437761 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527437872 |
ACTA1
|
Health Risk |
Pathogenic |
— |
| RS2527437890 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS2527437986 |
ACTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2527438087 |
ACTA1
|
Health Risk |
Pathogenic |
Nemaline myopathy, Nemaline myopathy |
| RS2527438829 |
ACTA1
|
Health Risk |
Likely pathogenic |
Progressive scapulohumeroperoneal distal myopathy, Progressive scapulohumeroperoneal distal myopathy |
| RS2527438840 |
ACTA1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy, Centronuclear myopathy |
| RS2527438844 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease, Actin accumulation myopathy |
| RS2527438980 |
ACTA1
|
Health Risk |
Likely pathogenic |
Myopathy, Myopathy |
| RS2527439036 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527439085 |
ACTA1
|
Health Risk |
Likely pathogenic |
Neuromuscular disease, Neuromuscular disease |
| RS2527439145 |
ACTA1
|
Health Risk |
Likely pathogenic |
Congenital myopathy 2c, severe infantile |
| RS2527439193 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527439205 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527439238 |
ACTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2527439283 |
ACTA1
|
Health Risk |
Pathogenic |
Nemaline myopathy, Nemaline myopathy |
| RS2527439307 |
ACTA1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy, Alpha-actinopathy |
| RS2527439378 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527439613 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527439653 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527439671 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527439716 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527439727 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527439836 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527439887 |
ACTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2527440009 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527440026 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527440067 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Parathyroid carcinoma |
| RS2527440074 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinal dystrophy |
| RS2527440081 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527440117 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2527440139 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527440176 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527440253 |
CDC73
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527440254 |
CDC73
|
Health Risk |
Likely pathogenic |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS2527440288 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527440357 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2527442444 |
KIDINS220
|
Health Risk |
Likely pathogenic |
— |
| RS2527445542 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527445568 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527445574 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2527445617 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2527448865 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527449218 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527449293 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527455766 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527455776 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527456144 |
KDM5B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 65 |
| RS2527474663 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527475132 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527486492 |
KDM5B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 65 |
| RS2527493724 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527493922 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527493958 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527499676 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527500635 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Parathyroid carcinoma |
| RS2527500780 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527500853 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527501083 |
REN
|
Health Risk |
Likely pathogenic |
— |
| RS2527502540 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527502777 |
HNRNPU
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527502885 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS2527504115 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527504511 |
HNRNPU
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2527505668 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527505699 |
HNRNPU
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527505715 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527505764 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527505914 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527506153 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |